Please assess the completion status of the following clinical trial:

Trial Title: Early Colonoscopy for Lower Gastrointestinal (GI) Bleeding

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients who are admitted with rectal bleeding and one of the following high-risk features:~1. HR \> 100/min~2. Systolic blood pressure \<100 mmHg~3. Orthostasis -considered as increase in HR by\> 20/min on assuming erect position as well as by decrease by 20 mmHg in systolic blood pressure~4. Need for blood transfusion~5. Drop in hemoglobin \> 1.5 g/dl or in hematocrit of \> 6% in 6 hours~Exclusion Criteria:~1. Inability to give informed consent~2. Peritoneal signs~3. Severe co-morbidities that would preclude the use of colonoscopy in standard clinical practice

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Early colonoscopy (Type: EXPERIMENTAL): Colonoscopy performed within 12 hours of presentation
- Elective colonoscopy (Type: ACTIVE_COMPARATOR): Colonoscopy 36-60 hours after presentation

Based on this trial design, predict the completion outcome and termination type (if applicable).